Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	phospholipid binding	ARHGAP32 MAPT PCLO ATG2B APBA1 OPHN1 C2CD5 GGA3 ITPR1 MYOF NCF1C NCF1B SNX1	9.68e-05	548	136	13	GO:0005543
GeneOntologyCellularComponent	inner dynein arm	DNAH3 DNAH2 DNAH7	3.06e-05	10	135	3	GO:0036156
GeneOntologyCellularComponent	dendrite	ARHGAP32 ANK3 CLIP2 MAPT PCLO CFTR ZMYND8 APBA1 MAGEE1 OPHN1 TTLL7 ITPR1 ARRB2 ALCAM NCF1C NCF1B SNX1	3.91e-05	858	135	17	GO:0030425
GeneOntologyCellularComponent	dendritic tree	ARHGAP32 ANK3 CLIP2 MAPT PCLO CFTR ZMYND8 APBA1 MAGEE1 OPHN1 TTLL7 ITPR1 ARRB2 ALCAM NCF1C NCF1B SNX1	4.02e-05	860	135	17	GO:0097447
GeneOntologyCellularComponent	axoneme	DNAH3 MAP4 MAPT CEP162 DNAH2 DNAH7 CFAP221 HYDIN	6.10e-05	207	135	8	GO:0005930
GeneOntologyCellularComponent	ciliary plasm	DNAH3 MAP4 MAPT CEP162 DNAH2 DNAH7 CFAP221 HYDIN	6.31e-05	208	135	8	GO:0097014
GeneOntologyCellularComponent	cytoplasmic region	DNAH3 MAP4 MAPT CEP162 PCLO DNAH2 DNAH7 PHLDB1 CFAP221 HYDIN	1.19e-04	360	135	10	GO:0099568
GeneOntologyCellularComponent	microtubule	DNAH3 CLIP2 MAP4 MAPT CEP162 DNAH2 NCKAP5 SHROOM2 CLIP1 DNAH7 TTLL7 TTLL13	1.80e-04	533	135	12	GO:0005874
GeneOntologyCellularComponent	somatodendritic compartment	ARHGAP32 ANK3 CLIP2 MAPT PCLO CFTR ZMYND8 APBA1 MAGEE1 SHROOM2 OPHN1 TTLL7 ITPR1 ARRB2 KCNJ11 ALCAM NCF1C NCF1B SNX1	3.47e-04	1228	135	19	GO:0036477
GeneOntologyCellularComponent	costamere	ANK3 AHNAK AHNAK2	3.71e-04	22	135	3	GO:0043034
GeneOntologyCellularComponent	axonemal dynein complex	DNAH3 DNAH2 DNAH7	5.46e-04	25	135	3	GO:0005858
GeneOntologyCellularComponent	supramolecular polymer	COL4A1 COL6A3 DNAH3 ANK3 CLIP2 MAP4 MAPT CEP162 DNAH2 NCKAP5 SHROOM2 CLIP1 DNAH7 TTLL7 XIRP2 AHNAK TTLL13 AHNAK2	6.37e-04	1187	135	18	GO:0099081
GeneOntologyCellularComponent	microtubule plus-end	CLIP2 NCKAP5 CLIP1	7.67e-04	28	135	3	GO:0035371
GeneOntologyCellularComponent	dendritic spine	ARHGAP32 MAPT ZMYND8 APBA1 OPHN1 ARRB2 SNX1	1.01e-03	242	135	7	GO:0043197
GeneOntologyCellularComponent	plasma membrane bounded cell projection cytoplasm	DNAH3 MAP4 MAPT CEP162 DNAH2 DNAH7 CFAP221 HYDIN	1.07e-03	317	135	8	GO:0032838
GeneOntologyCellularComponent	neuron spine	ARHGAP32 MAPT ZMYND8 APBA1 OPHN1 ARRB2 SNX1	1.13e-03	247	135	7	GO:0044309
GeneOntologyCellularComponent	supramolecular fiber	COL6A3 DNAH3 ANK3 CLIP2 MAP4 MAPT CEP162 DNAH2 NCKAP5 SHROOM2 CLIP1 DNAH7 TTLL7 XIRP2 AHNAK TTLL13 AHNAK2	1.57e-03	1179	135	17	GO:0099512
GeneOntologyCellularComponent	T-tubule	ANK3 AHNAK KCNJ11 AHNAK2	1.72e-03	79	135	4	GO:0030315
GeneOntologyCellularComponent	microtubule end	CLIP2 NCKAP5 CLIP1	1.88e-03	38	135	3	GO:1990752
GeneOntologyCellularComponent	cilium	DNAH3 MAP4 MAPT CEP162 DNAH2 AKAP3 SSX1 DNAH7 TTLL7 PHYH CFAP221 POC1B HYDIN TTLL13	2.03e-03	898	135	14	GO:0005929
HumanPheno	Abnormal sperm motility	DNAH2 AKAP3 SSX1 DNAH7 BRDT CFAP221 HYDIN	2.96e-05	115	41	7	HP:0012206
HumanPheno	Abnormal sperm physiology	DNAH2 AKAP3 SSX1 DNAH7 BRDT CFAP221 HYDIN	2.96e-05	115	41	7	HP:0034809
Domain	zf-C2H2_11	ZNF532 ZNF592 ZNF667	2.75e-05	9	131	3	PF16622
Domain	UBN_middle_dom	UBN2 UBN1	4.88e-05	2	131	2	IPR026947
Domain	HUN	UBN2 UBN1	4.88e-05	2	131	2	PF08729
Domain	HRD	UBN2 UBN1	4.88e-05	2	131	2	IPR014840
Domain	UBN_AB	UBN2 UBN1	4.88e-05	2	131	2	PF14075
Domain	PDZ	PCLO APBA1 MAGI3 SHROOM2 AHNAK ARHGAP21 AHNAK2	9.49e-05	151	131	7	PS50106
Domain	PDZ	PCLO APBA1 MAGI3 SHROOM2 AHNAK ARHGAP21 AHNAK2	9.89e-05	152	131	7	IPR001478
Domain	Dynein_heavy_chain_D4_dom	DNAH3 DNAH2 DNAH7	1.16e-04	14	131	3	IPR024317
Domain	Dynein_HC_stalk	DNAH3 DNAH2 DNAH7	1.16e-04	14	131	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH3 DNAH2 DNAH7	1.16e-04	14	131	3	IPR013602
Domain	DHC_N2	DNAH3 DNAH2 DNAH7	1.16e-04	14	131	3	PF08393
Domain	MT	DNAH3 DNAH2 DNAH7	1.16e-04	14	131	3	PF12777
Domain	AAA_8	DNAH3 DNAH2 DNAH7	1.16e-04	14	131	3	PF12780
Domain	DHC_fam	DNAH3 DNAH2 DNAH7	1.44e-04	15	131	3	IPR026983
Domain	Dynein_heavy	DNAH3 DNAH2 DNAH7	1.44e-04	15	131	3	PF03028
Domain	Dynein_heavy_dom	DNAH3 DNAH2 DNAH7	1.44e-04	15	131	3	IPR004273
Domain	TAU_MAP_2	MAP4 MAPT	1.46e-04	3	131	2	PS51491
Domain	Tubulin-binding	MAP4 MAPT	1.46e-04	3	131	2	PF00418
Domain	MAP_tubulin-bd_rpt	MAP4 MAPT	1.46e-04	3	131	2	IPR001084
Domain	TAU_MAP_1	MAP4 MAPT	1.46e-04	3	131	2	PS00229
Domain	MAP2/MAP4/Tau	MAP4 MAPT	1.46e-04	3	131	2	IPR027324
Domain	CTF_NFI	NFIA NFIB	2.90e-04	4	131	2	PF00859
Domain	CTF_NFI_1	NFIA NFIB	2.90e-04	4	131	2	PS00349
Domain	CTF_NFI_2	NFIA NFIB	2.90e-04	4	131	2	PS51080
Domain	CTF/NFI_DNA-bd-dom	NFIA NFIB	2.90e-04	4	131	2	IPR020604
Domain	NfI_DNAbd_pre-N	NFIA NFIB	2.90e-04	4	131	2	PF10524
Domain	CTF/NFI	NFIA NFIB	2.90e-04	4	131	2	IPR000647
Domain	CTF/NFI_DNA-bd_N	NFIA NFIB	2.90e-04	4	131	2	IPR019548
Domain	CTF/NFI_DNA-bd_CS	NFIA NFIB	2.90e-04	4	131	2	IPR019739
Domain	PDZ	APBA1 MAGI3 SHROOM2 AHNAK ARHGAP21 AHNAK2	4.80e-04	141	131	6	PF00595
Domain	PDZ	APBA1 MAGI3 SHROOM2 AHNAK ARHGAP21 AHNAK2	6.20e-04	148	131	6	SM00228
Domain	-	APBA1 MAGI3 SHROOM2 AHNAK ARHGAP21 AHNAK2	6.65e-04	150	131	6	2.30.42.10
Domain	UBA-like	HUWE1 TDRD3 SPATS2L N4BP2	1.06e-03	64	131	4	IPR009060
Domain	VPS9	VPS9D1 RIN2	1.33e-03	8	131	2	SM00167
Domain	-	CFAP221 HYDIN	1.33e-03	8	131	2	2.60.40.360
Domain	PapD-like	CFAP221 HYDIN	1.70e-03	9	131	2	IPR008962
Domain	CAP_GLY	CLIP2 CLIP1	2.12e-03	10	131	2	PF01302
Domain	CAP_GLY	CLIP2 CLIP1	2.12e-03	10	131	2	SM01052
Domain	VPS9	VPS9D1 RIN2	2.12e-03	10	131	2	PS51205
Domain	-	CLIP2 CLIP1	2.12e-03	10	131	2	2.30.30.190
Domain	CAP_GLY_1	CLIP2 CLIP1	2.12e-03	10	131	2	PS00845
Domain	CAP_GLY_2	CLIP2 CLIP1	2.12e-03	10	131	2	PS50245
Domain	CAP-Gly_domain	CLIP2 CLIP1	2.12e-03	10	131	2	IPR000938
Domain	VPS9	VPS9D1 RIN2	2.12e-03	10	131	2	PF02204
Domain	VPS9	VPS9D1 RIN2	2.12e-03	10	131	2	IPR003123
Domain	MAD_homology1_Dwarfin-type	NFIA NFIB	3.08e-03	12	131	2	IPR003619
Domain	DWA	NFIA NFIB	3.08e-03	12	131	2	SM00523
Domain	MH1	NFIA NFIB	3.08e-03	12	131	2	PF03165
Domain	AAA	DNAH3 CFTR DNAH2 DNAH7 NAV2	3.48e-03	144	131	5	SM00382
Domain	AAA+_ATPase	DNAH3 CFTR DNAH2 DNAH7 NAV2	3.48e-03	144	131	5	IPR003593
Domain	TTL	TTLL7 TTLL13	3.62e-03	13	131	2	PS51221
Domain	TTL/TTLL_fam	TTLL7 TTLL13	3.62e-03	13	131	2	IPR004344
Domain	TTL	TTLL7 TTLL13	3.62e-03	13	131	2	PF03133
Domain	ATPase_dyneun-rel_AAA	DNAH3 DNAH2	4.20e-03	14	131	2	IPR011704
Domain	CNH	VPS39 MAP4K1	4.20e-03	14	131	2	SM00036
Domain	AAA_5	DNAH3 DNAH2	4.20e-03	14	131	2	PF07728
Domain	CNH	VPS39 MAP4K1	4.83e-03	15	131	2	PF00780
Domain	CNH	VPS39 MAP4K1	4.83e-03	15	131	2	PS50219
Domain	CNH_dom	VPS39 MAP4K1	4.83e-03	15	131	2	IPR001180
Domain	RmlC_Cupin	CENPC VPS9D1	5.49e-03	16	131	2	IPR011051
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CENPC CEP162 ATG2B HUWE1 UBN2 F5 NSD3 LSM12 EPS15L1 ARRB2 UBN1 GTF3C2 ZNF592 AHNAK ZNF516 PPIL2 KDM1B MNAT1 SNX1 RAI1	1.57e-12	645	139	20	25281560
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	VPS39 LAD1 HUWE1 BCL7A TTC3 NSD3 GGA3 JAK3 MSX2 SCAF1 SLC7A1 MYOF TDRD3 EPS15L1 FASN PHLDB1 UBN1 ZNF592 AHNAK KCNJ11 ZNF516 NAV2 ARHGAP21 RAI1 AHNAK2	2.10e-12	1105	139	25	35748872
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	PDS5B MAP4 MAPT NELFA ZMYND8 ZNF217 HUWE1 CLIP1 C2CD5 PACS1 SCAF1 MYOF EPS15L1 FASN UBN1 NFIA ZNF592 CTR9 MAP4K1 ZNF516 ANKS1A	5.18e-12	774	139	21	15302935
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	EHBP1 ZMYND8 ATG2B ZNF217 HUWE1 FASN ARRB2 GTF3C2 ZNF532 ZNF592 N4BP2 AHNAK ZNF516 MGA ARHGAP21	1.55e-10	418	139	15	34709266
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	EHBP1 ANK3 MAP4 TSHZ2 MAPT CXXC5 MAGI3 HUWE1 UBN2 TTC3 SHROOM2 DHRS7B PACS1 SLC7A1 EPS15L1 PHLDB1 ARRB2 ZNF532 NFIA NFIB RIN2 ALCAM RAI1 ANKS1A	5.59e-09	1489	139	24	28611215
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	GPRASP1 ANK3 CLIP2 VPS39 ZMYND8 APBA1 CXXC5 MAGI3 NCKAP5 HUWE1 TTC3 SHROOM2 PRKRA VPS9D1 EPS15L1 ZNF532 ZNF592 CTR9 NMT2 MNAT1 ARHGAP21 SNX1	8.96e-09	1285	139	22	35914814
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	EHBP1 ARHGAP32 MAP4 MAPT CEP162 DCP2 MAGI3 DNAH7 NSD3 PHLDB1 MAP4K1 N4BP2 AHNAK NAV2 NCOA7 ARHGAP21 AHNAK2 ANKS1A	1.15e-08	861	139	18	36931259
Pubmed	Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance.	CCNB1 SLC7A1 NCF1C NCF1B	3.03e-08	9	139	4	10433265
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ANK3 MAP4 ATG2B HUWE1 UBN2 NSD3 GGA3 DHRS7B EPS15L1 FASN GTF3C2 AHNAK MGA SNX1	4.88e-08	549	139	14	38280479
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	EHBP1 ARHGAP32 ANK3 MAP4 LAD1 MAGI3 ELFN2 GGA3 EPS15L1 FASN AHNAK NAV2 ARHGAP21 SNX1	6.95e-08	565	139	14	25468996
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	REXO4 MAP4 SLC39A11 ZMYND8 CXXC5 ZNF217 BCL7A UBN2 NSD3 LSM12 SCAF1 MYOF TDRD3 SPATS2L GZF1 GTF3C2 ZNF592 NFIB CTR9 NMT2 KDM1B MNAT1	1.31e-07	1497	139	22	31527615
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	NELFA ZMYND8 ZNF217 BCL7A UBN2 NFIA NFIB CTR9 MGA RAI1	1.39e-07	268	139	10	33640491
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	PDS5B REXO4 CENPC UBN2 NSD3 NCBP3 UBN1 GTF3C2 NFIA ZNF592 PPIL2 KDM1B MGA RAI1	1.70e-07	608	139	14	36089195
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	ARHGAP32 ANK3 ZMYND8 MAGEE1 GGA3 ARRB2 UBN1 ZNF532 XIRP2 MAP4K1 CLSPN MGA	1.78e-07	430	139	12	35044719
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	REXO4 MAP4 MAPT UBN2 TTC3 CCNB1 PRKRA MYOF TDRD3 SPATS2L AHNAK MARF1 PPIL2 MGA AHNAK2	2.33e-07	724	139	15	36232890
Pubmed	Anakinra Activates Superoxide Dismutase 2 to Mitigate Inflammasome Activity.	CFTR NCF1C NCF1B	2.49e-07	4	139	3	34207085
Pubmed	AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration.	MYOF AHNAK AHNAK2	2.49e-07	4	139	3	17185750
Pubmed	Dysregulated Calcium Homeostasis in Cystic Fibrosis Neutrophils Leads to Deficient Antimicrobial Responses.	CFTR NCF1C NCF1B	2.49e-07	4	139	3	30120123
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	COL6A3 ARHGAP32 ZSCAN5DP TSHZ2 ZMYND8 NCKAP5 ITPR1 NCBP3 MYOF SPATS2L MGA	2.62e-07	363	139	11	14691545
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	USP45 ANK3 MAP4 VPS39 CEP162 HUWE1 UBN2 TTC3 SHROOM2 C2CD5 ITPR1 PACS1 SLC7A1 CTR9 MMP1 KDM1B MGA ARHGAP21	3.57e-07	1084	139	18	11544199
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	PDS5B CENPC MAP4 NELFA ZMYND8 NSD3 FASN UBN1 GTF3C2 ZNF532 XPO5 ZNF592 NFIB CTR9 AHNAK KDM1B MNAT1	6.79e-07	1014	139	17	32416067
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	PDS5B ANK3 ZMYND8 MAP3K4 NCBP3 PHLDB1 XIRP2 ZNF592 NAV2 ARHGAP21 HYDIN RAI1	8.21e-07	497	139	12	36774506
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	GPRASP1 ARHGAP32 ANK3 CLIP2 HUWE1 UBN2 TTC3 CLIP1 TDRD3 EPS15L1 N4BP2 ZNF516 MGA ARHGAP21 RAI1 ANKS1A	1.66e-06	963	139	16	28671696
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	PDS5B CENPC NELFA ZMYND8 NSD3 ARRB2 GTF3C2 BRDT NFIA ZNF592 KDM1B MGA	1.70e-06	533	139	12	30554943
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	REXO4 MAP4 BCL7A NSD3 CCNB1 NCBP3 TDRD3 FASN GTF3C2 PPIL2	2.60e-06	370	139	10	22922362
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	EHBP1 GPRASP1 ARHGAP32 ANK3 MAP4 MAPT PCLO ATG2B APBA1 HUWE1 SHROOM2 ELFN2 ITPR1 PRKRA LSM12 EPS15L1 SNX1	3.26e-06	1139	139	17	36417873
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	PDS5B NELFA UBN2 UBN1 CTR9 ZNF516 PPIL2 MGA	3.34e-06	222	139	8	37071664
Pubmed	A human MAP kinase interactome.	EHBP1 ARHGAP32 ANK3 CLIP2 NCKAP5 MAP3K4 NSD3 ARRB2 N4BP2 NAV2 MGA	4.45e-06	486	139	11	20936779
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	ZNF217 HUWE1 UBN2 BLK LSM12 TDRD3 UBN1 CTR9 N4BP2 ZNF516 PPIL2 CLSPN	4.64e-06	588	139	12	38580884
Pubmed	Functional proteomics mapping of a human signaling pathway.	ANK3 VPS8 ZMYND8 CXXC5 HUWE1 TTC3 GGA3 ARRB2 XPO5 ZNF592 CTR9 MGA	4.88e-06	591	139	12	15231748
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	EHBP1 ARHGAP32 CLIP2 MAGI3 UBN2 ELFN2 C2CD5 MYOF NFIA N4BP2 MGA	5.09e-06	493	139	11	15368895
Pubmed	Comparative mapping of the region of human chromosome 7 deleted in williams syndrome.	CLIP2 NCF1C NCF1B	5.16e-06	9	139	3	10330122
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	EHBP1 MAP4 ZMYND8 ATG2B GGA3 TDRD3 EPS15L1 FASN AHNAK ZNF667 NCOA7 ARHGAP21 SNX1 AHNAK2 ANKS1A	5.40e-06	934	139	15	33916271
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	PDS5B REXO4 CENPC MAP4 ZMYND8 UBN2 SSX1 NSD3 NCBP3 EPS15L1 UBN1 AHNAK MARF1 MGA RAI1	6.95e-06	954	139	15	36373674
Pubmed	The histone acetyltransferase KAT6A is recruited to unmethylated CpG islands via a DNA binding winged helix domain.	REXO4 NELFA CCNB1 PRKRA SCAF1 SPATS2L GZF1 GTF3C2 CTR9 MNAT1	7.44e-06	417	139	10	36537216
Pubmed	Fgf and Esrrb integrate epigenetic and transcriptional networks that regulate self-renewal of trophoblast stem cells.	ZMYND8 XPO5 ZNF592 CTR9 AHNAK ZNF516 MGA	7.61e-06	177	139	7	26206133
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	ZMYND8 ZNF217 HUWE1 TTC3 MYOF FASN UBN1 AHNAK AHNAK2	8.16e-06	332	139	9	37433992
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	MAP4 ZMYND8 HUWE1 FASN GTF3C2 XPO5 CTR9 AHNAK AHNAK2	8.16e-06	332	139	9	32786267
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	MAP4 ATG2B MYOF EPS15L1 FASN AHNAK SNX1 AHNAK2	9.48e-06	256	139	8	33397691
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	VPS39 DNAH2 CLIP1 ITPR1 MYOF FASN PHLDB1 XPO5 MGA ARHGAP21 SNX1 MAP3K19 ANKS1A	1.12e-05	754	139	13	35906200
Pubmed	Nuclear Factor IA Is Down-regulated in Muscle-invasive and High-grade Bladder Cancers.	NFIA NFIB	1.59e-05	2	139	2	34969759
Pubmed	FASN inhibition sensitizes metastatic OSCC cells to cisplatin and paclitaxel by downregulating cyclin B1.	CCNB1 FASN	1.59e-05	2	139	2	34510641
Pubmed	Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPARγ activation to decrease diet-induced obesity.	DHRS7B FASN	1.59e-05	2	139	2	22863804
Pubmed	The AHNAKs are a class of giant propeller-like proteins that associate with calcium channel proteins of cardiomyocytes and other cells.	AHNAK AHNAK2	1.59e-05	2	139	2	15007166
Pubmed	Functional pseudogenes inhibit the superoxide production.	NCF1C NCF1B	1.59e-05	2	139	2	26086043
Pubmed	Zinc finger proteins orchestrate active gene silencing during embryonic stem cell differentiation.	ZNF217 ZNF516	1.59e-05	2	139	2	29846698
Pubmed	UBN1/2 of HIRA complex is responsible for recognition and deposition of H3.3 at cis-regulatory elements of genes in mouse ES cells.	UBN2 UBN1	1.59e-05	2	139	2	30285846
Pubmed	Do PACS1 variants impeding adaptor protein binding predispose to syndromic intellectual disability?	GGA3 PACS1	1.59e-05	2	139	2	37141437
Pubmed	Expression of NFIA and NFIB within the murine spinal cord.	NFIA NFIB	1.59e-05	2	139	2	32068188
Pubmed	Physicians' perceived usefulness of and satisfaction with test reports for cystic fibrosis (DeltaF508) and factor V Leiden.	CFTR F5	1.59e-05	2	139	2	12792424
Pubmed	History-dependent catastrophes regulate axonal microtubule behavior.	CLIP2 CLIP1	1.59e-05	2	139	2	20471267
Pubmed	Nuclear Factor I A and Nuclear Factor I B Are Jointly Required for Mouse Postnatal Neural Stem Cell Self-Renewal.	NFIA NFIB	1.59e-05	2	139	2	38366751
Pubmed	AHNAK1 and AHNAK2 are costameric proteins: AHNAK1 affects transverse skeletal muscle fiber stiffness.	AHNAK AHNAK2	1.59e-05	2	139	2	20833135
Pubmed	Regulatory role of β-arrestin-2 in cholesterol processing in cystic fibrosis epithelial cells.	CFTR ARRB2	1.59e-05	2	139	2	22523395
Pubmed	Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma.	NFIA NFIB	1.59e-05	2	139	2	29577671
Pubmed	Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma.	NFIA NFIB	1.59e-05	2	139	2	31760595
Pubmed	The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells.	MAPT BLK ARRB2 MAP4K1 FGR ANKS1A	1.73e-05	134	139	6	24658140
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	VPS39 PCLO TTC3 NCBP3 PRKRA LSM12 PACS1 TDRD3 GTF3C2 NFIB	1.80e-05	462	139	10	31138677
Pubmed	In silico prediction of physical protein interactions and characterization of interactome orphans.	MAPT BLK ARRB2 MAP4K1 FGR ANKS1A	1.88e-05	136	139	6	25402006
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	PDS5B CENPC PCLO DNAH2 MAGI3 TTC3 DHRS7B FASN TCHHL1 CTR9 FAM186A N4BP2 AHNAK MARF1 NAV2 ALCAM ARHGAP21 RAI1	1.88e-05	1442	139	18	35575683
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	PDS5B HUWE1 CCNB1 NCBP3 GTF3C2 ZNF592 N4BP2 AHNAK HYDIN ANKS1A	2.05e-05	469	139	10	27634302
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH3 DNAH2 DNAH7	2.20e-05	14	139	3	9373155
Pubmed	BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.	ATG2B MYOF EPS15L1 FASN AHNAK SNX1 AHNAK2	2.76e-05	216	139	7	31519766
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	EHBP1 ARHGAP32 ANK3 MAP4 ATG2B MAGI3 EPS15L1 FASN XPO5 AHNAK ARHGAP21 ANKS1A	2.92e-05	708	139	12	39231216
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	ARHGAP32 CLIP2 PCLO PACS1 TDRD3 PHLDB1 ARRB2	2.92e-05	218	139	7	33378226
Pubmed	A quantitative protein interaction network for the ErbB receptors using protein microarrays.	BLK JAK3 RIN2 FGR ANKS1A	3.17e-05	90	139	5	16273093
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	EHBP1 PDS5B VPS39 NELFA MAGI3 C2CD5 EPS15L1 SPATS2L XPO5 NCOA7 ALCAM ARHGAP21	3.40e-05	719	139	12	35337019
Pubmed	Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance.	EHBP1 MAP4 CEP162 CLIP1 EPS15L1 FASN MGA	3.68e-05	226	139	7	31452512
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	DNAH3 DNAH2 MAGEE1 SHROOM2 DNAH7 SCAF1 XIRP2	4.46e-05	233	139	7	37704626
Pubmed	Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome.	NCF1C NCF1B	4.75e-05	3	139	2	27044504
Pubmed	NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury.	NCF1C NCF1B	4.75e-05	3	139	2	18787174
Pubmed	Deficient production of reactive oxygen species leads to severe chronic DSS-induced colitis in Ncf1/p47phox-mutant mice.	NCF1C NCF1B	4.75e-05	3	139	2	24873968
Pubmed	p47(phox) is required for afferent arteriolar contractile responses to angiotensin II and perfusion pressure in mice.	NCF1C NCF1B	4.75e-05	3	139	2	22184329
Pubmed	Natural Loss-of-Function Mutations in Qa2 and NCF1 Cause the Spread of Mannan-Induced Psoriasis.	NCF1C NCF1B	4.75e-05	3	139	2	33545139
Pubmed	Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis.	NCF1C NCF1B	4.75e-05	3	139	2	20142487
Pubmed	p47(phox) contributes to albuminuria and kidney fibrosis in mice.	NCF1C NCF1B	4.75e-05	3	139	2	25565313
Pubmed	Knockout of neutrophil cytosolic factor 1 ameliorates neuroinflammation and motor deficit after traumatic brain injury.	NCF1C NCF1B	4.75e-05	3	139	2	39357591
Pubmed	Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells.	NCF1C NCF1B	4.75e-05	3	139	2	11435342
Pubmed	Neutrophil Cytosolic Factor 1 in Dendritic Cells Promotes Autoreactive CD8+ T Cell Activation via Cross-Presentation in Type 1 Diabetes.	NCF1C NCF1B	4.75e-05	3	139	2	31118934
Pubmed	Virulence comparisons of Aspergillus nidulans mutants are confounded by the inflammatory response of p47phox-/- mice.	NCF1C NCF1B	4.75e-05	3	139	2	16041040
Pubmed	Intermittent hypoxia has organ-specific effects on oxidative stress.	NCF1C NCF1B	4.75e-05	3	139	2	18703411
Pubmed	Mycobacteria-induced Gr-1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion.	NCF1C NCF1B	4.75e-05	3	139	2	17307863
Pubmed	Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss.	NCF1C NCF1B	4.75e-05	3	139	2	27829407
Pubmed	The presence of p47phox in liver parenchymal cells is a key mediator in the pathogenesis of alcoholic liver steatosis.	NCF1C NCF1B	4.75e-05	3	139	2	22376231
Pubmed	Leishmania amazonensis amastigotes trigger neutrophil activation but resist neutrophil microbicidal mechanisms.	NCF1C NCF1B	4.75e-05	3	139	2	23918780
Pubmed	NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells.	NCF1C NCF1B	4.75e-05	3	139	2	28274989
Pubmed	Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II.	NCF1C NCF1B	4.75e-05	3	139	2	12364355
Pubmed	NOX2-Deficient Neutrophils Facilitate Joint Inflammation Through Higher Pro-Inflammatory and Weakened Immune Checkpoint Activities.	NCF1C NCF1B	4.75e-05	3	139	2	34557202
Pubmed	Reactive Oxygen Species Regulate Both Priming and Established Arthritis, but with Different Mechanisms.	NCF1C NCF1B	4.75e-05	3	139	2	28467721
Pubmed	P47(phox)-deficient NADPH oxidase defect in neutrophils of diabetic mouse strains, C57BL/6J-m db/db and db/+.	NCF1C NCF1B	4.75e-05	3	139	2	10670582
Pubmed	Direct Comparison of a Natural Loss-Of-Function Single Nucleotide Polymorphism with a Targeted Deletion in the Ncf1 Gene Reveals Different Phenotypes.	NCF1C NCF1B	4.75e-05	3	139	2	26528554
Pubmed	The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis.	NCF1C NCF1B	4.75e-05	3	139	2	19052348
Pubmed	Cyclin B interaction with microtubule-associated protein 4 (MAP4) targets p34cdc2 kinase to microtubules and is a potential regulator of M-phase microtubule dynamics.	MAP4 CCNB1	4.75e-05	3	139	2	7876309
Pubmed	Effect of early particulate air pollution exposure on obesity in mice: role of p47phox.	NCF1C NCF1B	4.75e-05	3	139	2	20864666
Pubmed	Reactive oxygen species delay control of lymphocytic choriomeningitis virus.	NCF1C NCF1B	4.75e-05	3	139	2	23328631
Pubmed	p47phox-Dependent Oxidant Signalling through ASK1, MKK3/6 and MAPKs in Angiotensin II-Induced Cardiac Hypertrophy and Apoptosis.	NCF1C NCF1B	4.75e-05	3	139	2	34572995
Pubmed	Acid aspiration-induced lung inflammation and injury are exacerbated in NADPH oxidase-deficient mice.	NCF1C NCF1B	4.75e-05	3	139	2	17114280
Pubmed	B-cell epitope spreading and inflammation in a mouse model of arthritis is associated with a deficiency in reactive oxygen species production.	NCF1C NCF1B	4.75e-05	3	139	2	25989352
Pubmed	Peroxisomal lipid synthesis regulates inflammation by sustaining neutrophil membrane phospholipid composition and viability.	DHRS7B FASN	4.75e-05	3	139	2	25565205
Pubmed	Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase.	NCF1C NCF1B	4.75e-05	3	139	2	17404617
Interaction	POLR1G interactions	PDS5B REXO4 CENPC ZMYND8 HUWE1 UBN2 NSD3 NCBP3 XPO5 POLR3E ZNF592 CTR9 ZNF516 PPIL2 CLSPN MGA RAI1 FGFBP1	6.11e-09	489	137	18	int:POLR1G
Interaction	MAPRE3 interactions	CENPC CLIP2 MAP4 MAPT CEP162 NCKAP5 CLIP1 TDRD3 MARF1 NAV2 ARHGAP21	5.05e-07	230	137	11	int:MAPRE3
Interaction	TOP3B interactions	VPS39 LAD1 APBA1 HUWE1 BCL7A TTC3 NSD3 GGA3 LSM12 JAK3 MSX2 SCAF1 SLC7A1 MYOF TDRD3 EPS15L1 FASN PHLDB1 UBN1 XPO5 ZNF592 AHNAK KCNJ11 ZNF516 NAV2 ARHGAP21 RAI1 AHNAK2	5.41e-07	1470	137	28	int:TOP3B
Interaction	ASF1A interactions	CENPC NELFA UBN2 NSD3 FASN UBN1 ZNF592 ZNF516 CLSPN MGA RAI1	1.11e-06	249	137	11	int:ASF1A
Interaction	KDM1A interactions	EHBP1 MAPT CEP162 INSM1 ZMYND8 ATG2B ZNF217 HUWE1 ELOF1 FASN ARRB2 GTF3C2 ZNF532 XPO5 ZNF592 N4BP2 AHNAK ZNF516 KDM1B MGA ARHGAP21	1.53e-06	941	137	21	int:KDM1A
Interaction	H2BC8 interactions	PDS5B REXO4 CENPC NELFA ZMYND8 NSD3 NCBP3 GTF3C2 NFIA ZNF592 NFIB PPIL2 KDM1B MGA MNAT1 RAI1	1.95e-06	576	137	16	int:H2BC8
Interaction	H3C1 interactions	PDS5B REXO4 ANK3 CENPC MAPT ZMYND8 DNAH2 UBN2 NSD3 SPATS2L UBN1 GTF3C2 NFIA XIRP2 CTR9 AHNAK NAV2 PPIL2 KDM1B MGA	3.02e-06	901	137	20	int:H3C1
Interaction	NUP43 interactions	PDS5B REXO4 CENPC MAP4 ZMYND8 CCDC168 UBN2 NSD3 NCBP3 SCAF1 ZNF532 NFIA ZNF592 MARF1 MGA AHNAK2	5.54e-06	625	137	16	int:NUP43
Interaction	BRD3 interactions	PDS5B CENPC ZMYND8 BCL7A C2CD5 NSD3 SCAF1 ARRB2 GTF3C2 NFIA ZNF592 KDM1B MGA RAI1	7.10e-06	494	137	14	int:BRD3
Interaction	KLF12 interactions	REXO4 ZNF217 FASN GZF1 NFIA NFIB ZNF516 ZNF667 MGA	7.32e-06	194	137	9	int:KLF12
Interaction	CADPS interactions	MAPT ZMYND8 TTC3 CLIP1 MARF1 ANKS1A	1.12e-05	74	137	6	int:CADPS
Interaction	H2BC5 interactions	PDS5B REXO4 MAP4 PCLO VPS8 HUWE1 NCBP3 PRKRA MSX2 SCAF1 FGFBP1	1.67e-05	331	137	11	int:H2BC5
Interaction	PHF21A interactions	EHBP1 ZMYND8 ATG2B ZNF217 HUWE1 ARRB2 ZNF592 AHNAK ZNF516 MGA ARHGAP21	2.32e-05	343	137	11	int:PHF21A
Interaction	RCOR1 interactions	EHBP1 ZMYND8 ATG2B ZNF217 HUWE1 FASN ARRB2 ZNF592 NFIB AHNAK ZNF516 MGA ARHGAP21	3.32e-05	494	137	13	int:RCOR1
Interaction	MIB1 interactions	CEP162 C2CD5 MAP3K4 TDRD3 EPS15L1 FASN ZDHHC23 XPO5 N4BP2 MGA	3.46e-05	295	137	10	int:MIB1
Interaction	RPL36 interactions	REXO4 CENPC MAPT CFTR PRKRA MSX2 SCAF1 TDRD3 FASN ARRB2 SPATS2L GZF1 BRDT	4.08e-05	504	137	13	int:RPL36
Interaction	PAX6 interactions	REXO4 INSM1 BCL7A UBN2 TTC3 ELOF1 GTF3C2 NFIA NFIB ZNF516 MGA	4.20e-05	366	137	11	int:PAX6
Interaction	YWHAH interactions	EHBP1 ARHGAP32 MAPT CEP162 CFTR MAGI3 HUWE1 DNAH7 NSD3 TTLL7 PACS1 PHLDB1 ARRB2 AHNAK NAV2 NCOA7 PPIL2 ARHGAP21 AHNAK2 ANKS1A	5.59e-05	1102	137	20	int:YWHAH
Interaction	TRIM36 interactions	MAP4 MAPT CEP162 CLIP1 CCNB1 TDRD3 ARHGAP21	5.83e-05	144	137	7	int:TRIM36
Interaction	RAB5C interactions	MAPT CFTR VPS8 ATG2B IMPACT HUWE1 TTC3 C2CD5 SLC7A1 MYOF FASN ARRB2 RIN2 ALCAM	6.06e-05	600	137	14	int:RAB5C
Interaction	CDH1 interactions	EHBP1 ARHGAP32 ANK3 MAP4 CFTR LAD1 MAGI3 ELFN2 GGA3 CCNB1 EPS15L1 FASN AHNAK NAV2 ARHGAP21 SNX1	6.81e-05	768	137	16	int:CDH1
Interaction	H1-5 interactions	EHBP1 GPRASP1 REXO4 CENPC MAP4 CCDC168 CCNB1 MSX2 SCAF1 XIRP2 TCHHL1 CCDC116	7.79e-05	463	137	12	int:H1-5
Interaction	TBR1 interactions	CFTR ZNF217 BCL7A BRDT NFIA NFIB	1.23e-04	113	137	6	int:TBR1
Interaction	FLNA interactions	USP45 ANK3 MAP4 MAPT CEP162 CFTR LAD1 GGA3 CCNB1 FASN ARRB2 AHNAK POC1B ARHGAP21	1.36e-04	648	137	14	int:FLNA
Interaction	ANXA2 interactions	PDS5B MAPT CFTR HUWE1 MAP3K4 TTLL7 MSX2 ARRB2 AHNAK ARHGAP21 AHNAK2	1.40e-04	419	137	11	int:ANXA2
Interaction	KPNA4 interactions	MAPT HUWE1 NCBP3 FASN ARRB2 ZNF532 MNAT1 RAI1	1.55e-04	225	137	8	int:KPNA4
Interaction	H3-3A interactions	PDS5B REXO4 CENPC MAPT UBN2 NSD3 NCBP3 UBN1 GTF3C2 NFIA ZNF592 PPIL2 KDM1B MGA RAI1	1.79e-04	749	137	15	int:H3-3A
GeneFamily	PDZ domain containing	PCLO APBA1 MAGI3 SHROOM2 AHNAK ARHGAP21 AHNAK2	1.16e-05	152	91	7	1220
GeneFamily	Dyneins, axonemal	DNAH3 DNAH2 DNAH7	7.97e-05	17	91	3	536
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	MAPT ELFN2 ITPR1 UBN1 MARF1 HYDIN	3.05e-04	181	91	6	694
GeneFamily	VPS9 domain containing	VPS9D1 RIN2	1.10e-03	10	91	2	928
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP32 OPHN1 ARHGAP21	2.04e-03	50	91	3	721
GeneFamily	Tubulin tyrosine ligase family	TTLL7 TTLL13	2.19e-03	14	91	2	779
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	GPRASP1 ANK3 TSHZ2 PCLO ZMYND8 APBA1 MAGI3 UBN2 TTC3 SHROOM2 CLIP1 C2CD5 TTLL7 PACS1 N4BP2 ZNF816 NCOA7 HYDIN SNX1 RAI1 AHNAK2	3.48e-07	1106	138	21	M39071
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	EHBP1 PDS5B CENPC ZMYND8 CLIP1 C2CD5 MAP3K4 ITPR1 SLC7A1 MYOF TDRD3 GTF3C2 NFIB NMT2 RIN2 ALCAM MNAT1 ANKS1A	6.12e-07	856	138	18	M4500
Coexpression	MARTINEZ_TP53_TARGETS_DN	ANK3 MAP4 SLC39A11 LAD1 CXXC5 IMPACT HUWE1 LSM12 MSX2 XPO5 NFIA NFIB NAV2 MGA FGFBP1	9.26e-07	615	138	15	M8673
Coexpression	GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP	DCP2 LAD1 ZNF217 MAGEE1 TTC3 NSD3 ZDHHC23 NCOA7 AHNAK2	1.20e-06	200	138	9	M8954
Coexpression	MARTINEZ_TP53_TARGETS_DN	ANK3 MAP4 SLC39A11 LAD1 CXXC5 IMPACT HUWE1 LSM12 MSX2 XPO5 NFIA NFIB NAV2 MGA FGFBP1	2.17e-06	659	138	15	MM1040
Coexpression	MARTINEZ_RB1_AND_TP53_TARGETS_DN	ANK3 MAP4 SLC39A11 LAD1 CXXC5 IMPACT HUWE1 LSM12 MSX2 XPO5 NFIA NFIB NAV2 MGA	4.40e-06	610	138	14	M3854
Coexpression	SMID_BREAST_CANCER_BASAL_DN	PDS5B ARHGAP32 CILP MAPT PCLO ZMYND8 CRAT ITPR1 MSX2 FASN NFIA AHNAK ALCAM RAB26 SNX1	4.44e-06	699	138	15	M4960
Coexpression	AIZARANI_LIVER_C39_EPCAM_POS_BILE_DUCT_CELLS_4	MAP4 CFTR LAD1 SLC7A1 SPATS2L AHNAK NCOA7 ALCAM	6.18e-06	184	138	8	M39135
Coexpression	MARTINEZ_RB1_AND_TP53_TARGETS_DN	ANK3 MAP4 SLC39A11 LAD1 CXXC5 IMPACT HUWE1 LSM12 MSX2 XPO5 NFIA NFIB NAV2 MGA	9.03e-06	650	138	14	MM1042
Coexpression	BOYLAN_MULTIPLE_MYELOMA_D_DN	PRKRA AHNAK PXYLP1 NCF1C NCF1B ARHGAP21	1.06e-05	94	138	6	MM787
Coexpression	GSE360_CTRL_VS_L_MAJOR_MAC_UP	PDS5B VPS39 DCP2 CRAT DNAH7 PHYH AHNAK RIN2	1.14e-05	200	138	8	M5160
Coexpression	GSE7852_TREG_VS_TCONV_LN_UP	LAD1 VPS8 DNAH7 PRKRA ZDHHC23 AHNAK ZNF516 ARHGAP21	1.14e-05	200	138	8	M5727
Coexpression	LANDIS_BREAST_CANCER_PROGRESSION_DN	COL4A1 COL6A3 MAP4 PHYH AHNAK	3.96e-05	72	138	5	M9908
Coexpression	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3	ARHGAP32 CLIP2 LAD1 ZMYND8 CXXC5 CLIP1 SLC7A1 MYOF PHLDB1 SPATS2L ZNF592 AHNAK RIN2 ALCAM ARHGAP21	3.98e-05	843	138	15	M2356
Coexpression	MURARO_PANCREAS_BETA_CELL	GPRASP1 CENPC MAPT PCLO INSM1 HUWE1 TTC3 CLIP1 C2CD5 TTLL7 SLC7A1 FASN UBN1 KCNJ11 NAV2 ALCAM	3.99e-05	946	138	16	M39169
Coexpression	LANDIS_BREAST_CANCER_PROGRESSION_DN	COL4A1 COL6A3 MAP4 PHYH AHNAK	4.83e-05	75	138	5	MM1084
Coexpression	FINETTI_BREAST_CANCER_KINOME_GREEN	JAK3 MAP4K1 FGR	7.61e-05	16	138	3	M12692
Coexpression	GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN	RASGRP4 SHROOM2 ELOF1 VPS9D1 ARRB2 NFIB FGFBP1	7.81e-05	194	138	7	M6492
Coexpression	GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP	COL4A1 ANK3 PCLO DNAH2 ITPR1 MSX2 MNAT1	8.33e-05	196	138	7	M8135
Coexpression	GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP	CEP162 DCP2 F5 DHRS7B EPS15L1 ZNF592 ZNF516	8.60e-05	197	138	7	M5363
Coexpression	GSE17721_POLYIC_VS_CPG_6H_BMDC_UP	MAGI3 CLIP1 MYOF PHLDB1 BRDT RIN2 FGR	9.45e-05	200	138	7	M3943
Coexpression	GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN	LAD1 DNAH7 JAK3 ZDHHC23 AHNAK ALCAM ARHGAP21	9.45e-05	200	138	7	M7426
Coexpression	GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN	ANK3 SLC39A11 AKAP3 ITPR1 AHNAK MMP1 MNAT1	9.45e-05	200	138	7	M6789
Coexpression	ZHAN_MULTIPLE_MYELOMA_CD2_DN	USP45 JAK3 FASN NFIA	1.10e-04	47	138	4	M17523
Coexpression	LANDIS_ERBB2_BREAST_TUMORS_324_DN	COL4A1 COL6A3 MAP4 PHYH PHLDB1 AHNAK	1.52e-04	151	138	6	M8901
Coexpression	FARMER_BREAST_CANCER_CLUSTER_7	MSX2 FASN ALCAM	1.52e-04	20	138	3	M10394
Coexpression	HE_LIM_SUN_FETAL_LUNG_C2_DC2_CELL	NCKAP5 BCL7A MAP4K1 ALCAM	1.64e-04	52	138	4	M45724
Coexpression	BUSSLINGER_GASTRIC_G_CELLS	ANK3 PCLO INSM1 SLC7A1 RAB26	1.73e-04	98	138	5	M40018
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	COL4A1 EHBP1 ANK3 PCLO NCKAP5 NFIA NFIB	1.75e-04	221	138	7	M39222
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	EHBP1 ZMYND8 CLIP1 C2CD5 SLC7A1 NFIB NMT2 MARF1 MNAT1 ANKS1A	1.87e-04	466	138	10	M13522
Coexpression	LANDIS_ERBB2_BREAST_TUMORS_324_DN	COL4A1 COL6A3 MAP4 PHYH PHLDB1 AHNAK	1.88e-04	157	138	6	MM1099
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 ANK3 TSHZ2 DNAH2 DNAH7 NFIA CFAP221 HYDIN MAP3K19 AHNAK2	5.13e-10	193	138	10	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGAP32 DNAH3 ANK3 TSHZ2 DNAH7 AHNAK ALCAM HYDIN MAP3K19	1.21e-08	198	138	9	d0ecace1fad24ce50b0935036fabb07e6c9e372d
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ARHGAP32 ANK3 TSHZ2 PCLO MYOF NFIB AHNAK ALCAM AHNAK2	1.32e-08	200	138	9	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ARHGAP32 ANK3 TSHZ2 PCLO MYOF NFIB AHNAK ALCAM AHNAK2	1.32e-08	200	138	9	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EHBP1 ANK3 NCKAP5 TTLL7 SPATS2L NFIA NFIB HYDIN	1.23e-07	186	138	8	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	DNAH3 ANK3 DNAH7 NFIA NFIB CFAP221 NAV2 HYDIN	1.77e-07	195	138	8	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	DNAH3 ANK3 DNAH7 NFIA NFIB CFAP221 NAV2 HYDIN	1.77e-07	195	138	8	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCLO INSM1 HUWE1 TTC3 TTLL7 ZNF516 NAV2 MGA	1.77e-07	195	138	8	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCLO INSM1 HUWE1 TTC3 TTLL7 ZNF516 NAV2 MGA	1.77e-07	195	138	8	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	DNAH3 ANK3 DNAH7 NFIB CFAP221 NAV2 CLSPN HYDIN	1.84e-07	196	138	8	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	DNAH3 ANK3 DNAH7 NFIB CFAP221 NAV2 CLSPN HYDIN	1.84e-07	196	138	8	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	NS-moderate-d_0-4-Epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ANK3 TSHZ2 TTC3 CLIP1 NFIA NFIB AHNAK ALCAM	2.15e-07	200	138	8	64462a18afca3c1a8548a857924b8166058bf958
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate\|2m / Sample Type, Dataset, Time_group, and Cell type.	ANK3 MAPT TTC3 NSD3 NFIA NFIB ARHGAP21 ANKS1A	2.15e-07	200	138	8	2a635694844ddabcd98462c5636a6f41a3f08a46
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	COL4A1 ANK3 MAGI3 NCKAP5 NAV2 NCOA7 ALCAM	1.04e-06	170	138	7	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D175\|Adult / Lineage, Cell type, age group and donor	ANK3 PCLO CFTR LAD1 SLC7A1 CFAP221 NCOA7	2.03e-06	188	138	7	ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCLO INSM1 IMPACT UBN2 TTC3 ZNF516 NAV2	2.03e-06	188	138	7	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ANK3 ZMYND8 TTLL7 ITPR1 MYOF NAV2 HYDIN	2.03e-06	188	138	7	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	LV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL4A1 COL6A3 TSHZ2 OPHN1 PHLDB1 NFIA NCOA7	2.18e-06	190	138	7	12992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCell	Control-Epithelial-Ciliated_cells\|Control / Condition, Lineage and Cell class	DNAH3 DNAH2 DNAH7 CFAP221 HYDIN MAP3K19 AHNAK2	2.26e-06	191	138	7	ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL4A1 COL6A3 TSHZ2 OPHN1 PHLDB1 NFIA NCOA7	2.26e-06	191	138	7	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	Control-Epithelial\|Control / Condition, Lineage and Cell class	DNAH3 DNAH2 DNAH7 CFAP221 HYDIN MAP3K19 AHNAK2	2.26e-06	191	138	7	6228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	DNAH3 ANK3 DNAH7 NFIB CFAP221 NAV2 HYDIN	2.59e-06	195	138	7	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	EHBP1 COL6A3 TSHZ2 OPHN1 PHLDB1 NFIA NAV2	2.59e-06	195	138	7	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL4A1 COL6A3 ARHGAP32 TSHZ2 PHLDB1 NFIA NCOA7	2.59e-06	195	138	7	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANK3 MAGI3 NCKAP5 CFAP221 NAV2 NCOA7 ALCAM	2.59e-06	195	138	7	9406866f99555198a9be311fbd65751b70f35446
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGAP32 DNAH3 AHNAK ALCAM HYDIN MAP3K19 AHNAK2	2.77e-06	197	138	7	5c4cee914baf7cb43e9cb99cc9e3ae823856dc15
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_PFC-23\|World / Primary Cells by Cluster	ANK3 MAPT PCLO TTC3 NSD3 TTLL7 FASN	2.77e-06	197	138	7	def63e7e28dd398722e528b7816a34de92552419
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_PFC\|World / Primary Cells by Cluster	ANK3 MAPT PCLO TTC3 NSD3 TTLL7 FASN	2.77e-06	197	138	7	26fd54acd90292a01ef0d892ba16ccdade987f36
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP32 ANK3 SLC39A11 MAGI3 OPHN1 PACS1 NFIA	2.96e-06	199	138	7	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Control-Epithelial_airway-Ciliated_cells-Ciliated\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 DNAH2 DNAH7 CFAP221 HYDIN MAP3K19	8.64e-06	154	138	6	4e3bc24043144143842627cacf6f90dda2228910
ToppCell	Control-Epithelial_airway-Ciliated_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 DNAH2 DNAH7 CFAP221 HYDIN MAP3K19	8.64e-06	154	138	6	7556a4b2b062da5ae7ec2bbb66e745e7662db628
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A1 COL6A3 TSHZ2 MAP3K4 FASN NAV2	1.57e-05	171	138	6	972fab891135bd755d5526cbc5a963200067b0a6
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A1 COL6A3 TSHZ2 MAP3K4 FASN NAV2	1.57e-05	171	138	6	2a77ed79c6f2e700e789c80451a70ecb31639719
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-RGCs_early_2\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	DNAH7 MSX2 MYOF NFIA HYDIN MAP3K19	1.84e-05	176	138	6	8e0ac3ad5e47614b4befabd674a40e3eaae553f3
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INSM1 DNAH2 MAP4K1 CLSPN HYDIN MAP3K19	1.97e-05	178	138	6	6178706db4a855d72abc156537604d575624df56
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INSM1 DNAH2 MAP4K1 CLSPN HYDIN MAP3K19	1.97e-05	178	138	6	f02076ece0fa899e620971c887ad4da7f48684ed
ToppCell	FF-Differ-KC\|World / shred by cell class for mouse tongue	PCLO CXXC5 MSX2 PHLDB1 RIN2 FGFBP1	2.03e-05	179	138	6	1526a130565a97c291a25a7a988089bffc1515c1
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH2 DNAH7 TTLL7 KDM1B HYDIN MAP3K19	2.09e-05	180	138	6	92fb01b91261b3103454924cde56add337b41844
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	ANK3 CFTR MAGI3 NAV2 NCOA7 ALCAM	2.16e-05	181	138	6	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	COVID-19-Epithelial_cells-ECM-high_epithelial\|COVID-19 / group, cell type (main and fine annotations)	COL4A1 COL6A3 ANK3 MAGI3 NCKAP5 NAV2	2.30e-05	183	138	6	dc1d380bf7564f290256cb7108063d1bd2da732b
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	COL4A1 PCLO MAGI3 NCKAP5 TTLL7 TNNI3K	2.30e-05	183	138	6	6821dca076318115d360ff426eb1218cfe104063
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL4A1 MAGI3 NCKAP5 TTLL7 NAV2 ALCAM	2.37e-05	184	138	6	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL4A1 MAGI3 NCKAP5 TTLL7 NAV2 ALCAM	2.37e-05	184	138	6	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL4A1 COL6A3 CILP TSHZ2 PHLDB1 NFIA	2.44e-05	185	138	6	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	ANK3 CFTR MAGI3 NFIA NAV2 ALCAM	2.44e-05	185	138	6	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 DNAH2 DNAH7 CFAP221 HYDIN MAP3K19	2.44e-05	185	138	6	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 DNAH2 DNAH7 CFAP221 HYDIN MAP3K19	2.52e-05	186	138	6	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	Control-Epithelial-Club\|World / Disease state, Lineage and Cell class	ANK3 CFTR MAGI3 NCKAP5 NFIB NAV2	2.52e-05	186	138	6	9798428691408e17ff2af2fe2d1b345f074d67e4
ToppCell	NS-moderate-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 DNAH2 DNAH7 CFAP221 HYDIN MAP3K19	2.52e-05	186	138	6	85787ff207f109ec7e3c0f729ba9bda739c2fdc9
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	VPS8 CRAT F5 SPATS2L GTF3C2 SLC37A4	2.59e-05	187	138	6	c8278525b3e1d3f3f4defcaf109cce22dd2e157a
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL4A1 COL6A3 TSHZ2 SSC5D PHLDB1 NFIB	2.59e-05	187	138	6	c104fbfef2d0bef64077ac721edf2379fd59d547
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANK3 TSHZ2 ZDHHC23 NFIB AHNAK RAB26	2.59e-05	187	138	6	f5a202d5f8eb57b57d80815ce98774e04c387383
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ANK3 MAGI3 FASN CFAP221 NAV2 ALCAM	2.67e-05	188	138	6	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	Mesenchymal-myofibroblast_cell\|World / Lineage, Cell type, age group and donor	COL4A1 COL6A3 TSHZ2 SSC5D PHLDB1 NFIB	2.75e-05	189	138	6	44e37f88137bb249933eb615235b2cf2ae7f3925
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_3\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	VPS8 CRAT F5 SPATS2L GTF3C2 SLC37A4	2.75e-05	189	138	6	99b01893da9f9f7c9528afaffad178285211738b
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 CFTR DNAH7 CFAP221 HYDIN MAP3K19	2.75e-05	189	138	6	cd4746ea6ae48a7dd14a2960d38d9445a738cf2c
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANK3 CENPC TSHZ2 JAK3 POLR3E NCOA7	2.84e-05	190	138	6	91ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell	COVID-19-lung-AT2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANK3 CFTR MAGI3 FASN CFAP221 ALCAM	2.84e-05	190	138	6	27a1a86620fe9b5ee930d388b32352206485e6d0
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DNAH3 DNAH2 DNAH7 CFAP221 HYDIN MAP3K19	2.92e-05	191	138	6	2a8e6d560907e71e9f6e190ca0667da804e25641
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EHBP1 ANK3 MAPT NCKAP5 NFIA NFIB	2.92e-05	191	138	6	3c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH3 DNAH2 DNAH7 CFAP221 HYDIN MAP3K19	2.92e-05	191	138	6	46c9d4d10c66c0fae1fa351924091b69ea2f38d4
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EHBP1 ANK3 MAPT NCKAP5 NFIA NFIB	2.92e-05	191	138	6	1c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCell	E15.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ANK3 MAGI3 PHYH NAV2 ALCAM FGFBP1	2.92e-05	191	138	6	402c341b00f98e8215458766b3c219fff8dcb447
ToppCell	Mild_COVID-19-Epithelial-Ciliated\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	DNAH3 DNAH2 DNAH7 CFAP221 HYDIN MAP3K19	2.92e-05	191	138	6	995e76bbf07674d95b8ef09e078cf6410af27a09
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	ANK3 PCLO CFTR MAGI3 FASN CFAP221	2.92e-05	191	138	6	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH3 DNAH2 DNAH7 CFAP221 HYDIN MAP3K19	2.92e-05	191	138	6	a37f20172b85566b9039254a89680e37fd503fd5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A1 NCKAP5 TTLL7 SPATS2L NFIB HYDIN	2.92e-05	191	138	6	1cb02007adb344f17ef73d58890f91298c7cf5a1
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH3 DNAH2 DNAH7 CFAP221 HYDIN MAP3K19	2.92e-05	191	138	6	2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANK3 CFTR MAGI3 CFAP221 NAV2 ALCAM	2.92e-05	191	138	6	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	ANK3 CFTR MAGI3 CFAP221 NAV2 ALCAM	3.01e-05	192	138	6	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	TSHZ2 F5 MAP3K4 JAK3 NFIA POLR3E	3.01e-05	192	138	6	1c0ce299cee9ab5cdea256f3e8c1e5598577a8b6
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-2\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CXXC5 BCL7A NSD3 BLK ZDHHC23 ZNF667	3.01e-05	192	138	6	ef86d82e4f04f9f54e821ef496d70fc81072d773
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	COL4A1 COL6A3 TSHZ2 OPHN1 PHLDB1 NCOA7	3.01e-05	192	138	6	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	COL6A3 ANK3 CENPC TSHZ2 JAK3 AHNAK	3.01e-05	192	138	6	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	15-Trachea-Epithelial-Intermediate_ciliated\|Trachea / Age, Tissue, Lineage and Cell class	ARHGAP32 SLC39A11 DNAH2 DNAH7 CFAP221 HYDIN	3.01e-05	192	138	6	9cbe961a800c981cdc742a47ed18e9c8eb6430bd
ToppCell	IPF-Epithelial-Ciliated\|IPF / Disease state, Lineage and Cell class	DNAH3 DNAH2 DNAH7 CFAP221 HYDIN MAP3K19	3.01e-05	192	138	6	354adc1354bf596fbc60dd45c0169688e6f45165
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANK3 CFTR MAGI3 FASN CFAP221 NCOA7	3.10e-05	193	138	6	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH3 DNAH2 DNAH7 CFAP221 HYDIN MAP3K19	3.10e-05	193	138	6	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	LV-01._Fibroblast_I\|LV / Chamber and Cluster_Paper	COL4A1 COL6A3 TSHZ2 OPHN1 PHLDB1 NCOA7	3.10e-05	193	138	6	dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANK3 CFTR MAGI3 FASN CFAP221 NCOA7	3.10e-05	193	138	6	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANK3 CFTR MAGI3 CFAP221 NAV2 ALCAM	3.10e-05	193	138	6	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	DNAH3 DNAH2 DNAH7 CFAP221 HYDIN MAP3K19	3.19e-05	194	138	6	756082a0f5953b52229bb60d40b84701cb6cb23d
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	COL4A1 COL6A3 TSHZ2 PHLDB1 NFIA NCOA7	3.19e-05	194	138	6	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-MGE2\|World / Primary Cells by Cluster	ANK3 MAPT PCLO SPATS2L ALCAM ANKS1A	3.19e-05	194	138	6	b42fd64b0fb95434a9e4e6586f31d26114a4074b
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10\|World / Primary Cells by Cluster	ANK3 MAPT PCLO SPATS2L ALCAM ANKS1A	3.19e-05	194	138	6	81e7bc6516ab8d02ccd1c76a56a3533b788c27c8
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	COL4A1 COL6A3 TSHZ2 PHLDB1 NFIA NCOA7	3.19e-05	194	138	6	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANK3 MAGI3 NCKAP5 NAV2 NCOA7 ALCAM	3.19e-05	194	138	6	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 DNAH2 DNAH7 CFAP221 HYDIN MAP3K19	3.19e-05	194	138	6	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	Mesenchymal_cells-Arteriolar_fibro.\|World / Lineage and Cell class	COL6A3 CILP SSC5D NFIB AHNAK AHNAK2	3.19e-05	194	138	6	c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ANK3 INSM1 BCL7A NFIB MNAT1 CCDC116	3.19e-05	194	138	6	b111d10c99d7ff7eb261cd7786cd9d9a549049b1
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CXXC5 BCL7A ITPR1 BLK ZDHHC23 ZNF667	3.19e-05	194	138	6	36ce99b9e4e1c968cc7ae381168124cc7c14afb2
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	COL6A3 TSHZ2 OPHN1 PHLDB1 NFIA NAV2	3.19e-05	194	138	6	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	COVID-19-Epithelial-Ciliated_cells\|COVID-19 / Condition, Lineage and Cell class	DNAH3 DNAH2 DNAH7 CFAP221 HYDIN MAP3K19	3.19e-05	194	138	6	43be5fbd51dd58839cb03ca3ddd05a458e1ddb74
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 DNAH2 DNAH7 CFAP221 HYDIN MAP3K19	3.28e-05	195	138	6	649fd2336e963f6a150d182a53ad5dd838ca80b1
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CXXC5 BCL7A ITPR1 BLK ZDHHC23 AHNAK	3.28e-05	195	138	6	481989d2e5bd2582da3d86b0155c4d6615317067
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CXXC5 BCL7A ITPR1 BLK ZDHHC23 AHNAK	3.28e-05	195	138	6	6108a27523d1b93a7fbe35cb95704a5ad9071e3c
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	COL6A3 TSHZ2 OPHN1 PHLDB1 NFIA NAV2	3.28e-05	195	138	6	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 DNAH2 DNAH7 CFAP221 HYDIN MAP3K19	3.28e-05	195	138	6	129ad5f4253ecb1a8477cc38773e6e91ea9570b0
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 DNAH2 DNAH7 CFAP221 HYDIN MAP3K19	3.28e-05	195	138	6	3e70ee987d66d450062d5df3d7c733ccc7344470
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH3 DNAH2 DNAH7 CFAP221 HYDIN MAP3K19	3.28e-05	195	138	6	3486eae5fdb062a75a907b896c9d7b396d2aa195
Drug	Ethamivan [304-84-7]; Up 200; 18uM; MCF7; HT_HG-U133A	GPRASP1 MAP4 CEP162 ITPR1 JAK3 PACS1 TDRD3 EPS15L1 DNAJC28 NFIB PPIL2	3.15e-08	197	137	11	7021_UP
Drug	Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	DNAH3 ANK3 MAP4 MAP3K4 MYOF EPS15L1 ARRB2 RIN2 RAB26	2.13e-06	188	137	9	6451_DN
Drug	Amphotericin B [1397-89-3]; Down 200; 4.4uM; MCF7; HT_HG-U133A	ANK3 MAP4 MAP3K4 PACS1 SLC7A1 TDRD3 NFIB RIN2 PPIL2	2.76e-06	194	137	9	3303_DN
Drug	Meprylcaine hydrochloride [956-03-6]; Up 200; 14.8uM; MCF7; HT_HG-U133A	CEP162 ZMYND8 BCL7A SSX1 MYOF TDRD3 PHLDB1 DNAJC28 PPIL2	3.12e-06	197	137	9	6204_UP
Drug	Levamisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A	MAP4 MAPT BCL7A MYOF TDRD3 DNAJC28 ZNF592 NFIB PPIL2	3.39e-06	199	137	9	2257_DN
Drug	(-)-MK 801 hydrogen maleate [77086-19-2]; Up 200; 11.8uM; HL60; HT_HG-U133A	ANK3 CLIP2 PCLO LAD1 BCL7A TTLL7 EPS15L1 MMP1 RAB26	3.54e-06	200	137	9	3081_UP
Drug	Hexetidine [141-94-6]; Up 200; 11.8uM; HL60; HT_HG-U133A	GPRASP1 CFTR ZMYND8 HUWE1 SSX1 PACS1 MYOF RIN2	1.67e-05	185	137	8	2457_UP
Drug	Dicumarol [66-76-2]; Up 200; 11.8uM; HL60; HT_HG-U133A	ANK3 CFTR SSX1 GGA3 PACS1 MYOF DNAJC28 MAP4K1	2.18e-05	192	137	8	2561_UP
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	VPS39 IMPACT NSD3 VPS9D1 NFIB NMT2 MARF1 AHNAK2	2.27e-05	193	137	8	1652_UP
Drug	Tetrandrine [518-34-3]; Down 200; 6.4uM; HL60; HT_HG-U133A	DNAH3 REXO4 MAP4 MAPT SLC7A1 TDRD3 MAP4K1 RIN2	2.35e-05	194	137	8	2520_DN
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A	DNAH3 MAP4 CEP162 ZMYND8 MYOF PHLDB1 DNAJC28 NFIB	2.35e-05	194	137	8	3539_DN
Drug	Methylatropine nitrate [52-88-0]; Up 200; 11uM; HL60; HT_HG-U133A	MAPT F5 TTLL7 PACS1 TDRD3 DNAJC28 MMP1 FGFBP1	2.53e-05	196	137	8	3116_UP
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A	PDS5B ATG2B SLC7A1 DNAJC28 NMT2 NAV2 PPIL2 ALCAM	2.53e-05	196	137	8	3268_DN
Drug	5152487; Down 200; 10uM; MCF7; HT_HG-U133A_EA	PDS5B ANK3 MAP4 MAPT CEP162 ZMYND8 IMPACT SLC7A1	2.53e-05	196	137	8	896_DN
Drug	Neostigmine bromide [114-80-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A	EHBP1 MAP4 ZMYND8 F5 GGA3 ITPR1 NMT2 ALCAM	2.63e-05	197	137	8	5335_UP
Drug	Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; HL60; HG-U133A	PDS5B ARHGAP32 MAP4 VPS8 DHRS7B JAK3 PPIL2 MGA	2.63e-05	197	137	8	1991_DN
Drug	Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	MAP4 ZMYND8 IMPACT ITPR1 ARRB2 RIN2 PPIL2 AHNAK2	2.63e-05	197	137	8	3308_DN
Drug	Ald1.1-H_000455; Down 200; 10uM; MCF7; HT_HG-U133A	MAP4 MAPT BCL7A DHRS7B SLC7A1 TDRD3 UBN1 MGA	2.72e-05	198	137	8	7542_DN
Drug	Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A	ZMYND8 BCL7A VPS9D1 PACS1 PHLDB1 RIN2 PPIL2 SNX1	2.72e-05	198	137	8	1491_DN
Drug	rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A	GPRASP1 MAP4 VPS39 SHROOM2 GGA3 TDRD3 ZNF516 PPIL2	2.72e-05	198	137	8	6992_UP
Drug	Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A	MAP4 MAPT VPS39 F5 ITPR1 VPS9D1 NAV2 ALCAM	2.82e-05	199	137	8	5337_UP
Drug	Suramin sodium salt; Up 200; 10uM; PC3; HT_HG-U133A	COL4A1 ZMYND8 IMPACT NSD3 TDRD3 NFIB AHNAK PPIL2	2.93e-05	200	137	8	7501_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ZMYND8 BCL7A CLIP1 MYOF TDRD3 RIN2 PPIL2	7.79e-05	170	137	7	3746_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	PDS5B ZMYND8 BCL7A CLIP1 SLC7A1 MYOF RIN2	9.01e-05	174	137	7	5745_DN
Drug	Es-7	CLIP2 CLIP1	1.07e-04	3	137	2	CID000074187
Drug	AC1L4P4M	CLIP2 CLIP1	1.07e-04	3	137	2	CID000161279
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ZMYND8 BCL7A CLIP1 NCBP3 MYOF TDRD3 RIN2	1.19e-04	182	137	7	5802_DN
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	EHBP1 PDS5B ZMYND8 NFIB MGA MNAT1 ANKS1A	1.23e-04	183	137	7	7498_DN
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	GPRASP1 ANK3 CEP162 ATG2B MYOF NMT2 MARF1	1.37e-04	186	137	7	1664_UP
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA	VPS39 CEP162 PHLDB1 DNAJC28 RIN2 MARF1 PPIL2	1.46e-04	188	137	7	1023_UP
Drug	Beclomethasone dipropionate [5534-09-8]; Up 200; 7.6uM; PC3; HT_HG-U133A	ZMYND8 F5 VPS9D1 NFIB AHNAK NAV2 PPIL2	1.61e-04	191	137	7	4580_UP
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A	GPRASP1 PCLO ZMYND8 CLIP1 MYOF AHNAK NMT2	1.61e-04	191	137	7	4168_DN
Drug	Carisoprodol [78-44-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A	CLIP2 NSD3 VPS9D1 MYOF TDRD3 ARRB2 NFIB	1.71e-04	193	137	7	3251_UP
Drug	Parbendazole [14255-87-9]; Down 200; 16.2uM; PC3; HT_HG-U133A	MAPT CEP162 ITPR1 PACS1 TDRD3 NFIB PPIL2	1.71e-04	193	137	7	3799_DN
Drug	Tetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A	PDS5B DNAH3 MAP4 CEP162 ZMYND8 PHLDB1 ZNF592	1.71e-04	193	137	7	6209_UP
Drug	Clemizole hydrochloride [1163-36-6]; Down 200; 11uM; PC3; HT_HG-U133A	GPRASP1 MAPT CEP162 ITPR1 MYOF NFIB PPIL2	1.71e-04	193	137	7	3672_DN
Drug	yohimbine; Up 200; 22.9uM; MCF7; HT_HG-U133A_EA	EHBP1 PDS5B DNAH3 MAP4 MAPT ATG2B SLC7A1	1.77e-04	194	137	7	1119_UP
Drug	Phenelzine sulfate [156-51-4]; Up 200; 17uM; PC3; HT_HG-U133A	CEP162 HUWE1 NSD3 GGA3 NFIB PPIL2 RAB26	1.77e-04	194	137	7	4538_UP
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; MCF7; HT_HG-U133A	MAPT LAD1 PACS1 SLC7A1 MYOF EPS15L1 PPIL2	1.77e-04	194	137	7	4990_DN
Drug	Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; MCF7; HT_HG-U133A	MAP4 MYOF TDRD3 ZNF592 RIN2 ZNF516 PPIL2	1.77e-04	194	137	7	6811_DN
Drug	Beta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A	MAPT MSX2 MYOF TDRD3 NFIB PPIL2 RAB26	1.77e-04	194	137	7	3807_DN
Drug	Indoprofen [31842-01-0]; Down 200; 14.2uM; PC3; HT_HG-U133A	DNAH3 CLIP2 CFTR NSD3 MSX2 TDRD3 PPIL2	1.77e-04	194	137	7	4249_DN
Drug	Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A	ARHGAP32 ANK3 ZMYND8 ZNF217 CLIP1 PACS1 RIN2	1.77e-04	194	137	7	4772_DN
Drug	Chloramphenicol [56-75-7]; Down 200; 12.4uM; PC3; HT_HG-U133A	MAPT CEP162 MYOF TDRD3 NFIB ZNF667 PPIL2	1.77e-04	194	137	7	5047_DN
Drug	estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A	MAP4 MAPT CEP162 ZMYND8 CRAT EPS15L1 NAV2	1.77e-04	194	137	7	7000_UP
Drug	Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A	ARHGAP32 DNAH3 MAP4 MAPT NSD3 PACS1 ZNF592	1.83e-04	195	137	7	6821_DN
Drug	Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; MCF7; HT_HG-U133A	MAP4 MAPT ZMYND8 MAP3K4 GGA3 PPIL2 ALCAM	1.83e-04	195	137	7	7239_DN
Drug	Naringenine [480-41-1]; Down 200; 14.6uM; PC3; HT_HG-U133A	CEP162 ZMYND8 DNAH7 TTLL7 MYOF ZNF667 RAB26	1.83e-04	195	137	7	4597_DN
Drug	Sotalol hydrochloride [959-24-0]; Down 200; 13uM; HL60; HT_HG-U133A	VPS39 VPS8 MAP3K4 NSD3 ZNF667 PPIL2 ANKS1A	1.83e-04	195	137	7	2918_DN
Drug	Lactobionic acid [96-82-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A	VPS8 ITPR1 NFIB RIN2 MARF1 FGR AHNAK2	1.83e-04	195	137	7	3246_UP
Drug	Levonordefrin [829-74-3]; Down 200; 21.8uM; HL60; HT_HG-U133A	REXO4 MAP4 SSX1 SLC7A1 MYOF EPS15L1 ZNF667	1.89e-04	196	137	7	2710_DN
Drug	Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; MCF7; HT_HG-U133A	ZMYND8 IMPACT PACS1 ZNF592 PPIL2 ALCAM SNX1	1.89e-04	196	137	7	7329_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	ARHGAP32 MAP4 BCL7A CRAT GGA3 ARRB2 RAB26	1.89e-04	196	137	7	1628_DN
Drug	2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A_EA	PDS5B MAP4 MAPT SLC7A1 NFIB NMT2 RAB26	1.89e-04	196	137	7	1078_UP
Drug	Mecamylamine hydrochloride [826-39-1]; Up 200; 19.6uM; PC3; HT_HG-U133A	COL4A1 PDS5B NSD3 TTLL7 PACS1 ARRB2 PPIL2	1.89e-04	196	137	7	7263_UP
Drug	fluphenazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A	ARHGAP32 ANK3 CLIP2 MAPT IMPACT AHNAK PPIL2	1.89e-04	196	137	7	2697_DN
Drug	3-bp	CFTR NFIA NFIB	1.92e-04	19	137	3	CID005326878
Drug	estradiol, USP; Down 200; 0.1uM; HL60; HT_HG-U133A	ANK3 CLIP2 MAPT ZMYND8 SSX1 DNAJC28 AHNAK	1.95e-04	197	137	7	2668_DN
Drug	Dydrogesterone [152-62-5]; Up 200; 12.8uM; HL60; HT_HG-U133A	ARHGAP32 CLIP2 MAP4 ZMYND8 TTLL7 AHNAK NMT2	1.95e-04	197	137	7	2156_UP
Drug	Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	CILP MAP4 NSD3 ITPR1 PHLDB1 PPIL2 ALCAM	1.95e-04	197	137	7	3934_DN
Drug	rofecoxib; Down 200; 10uM; HL60; HG-U133A	EHBP1 DNAH3 ANK3 MAP4 ITPR1 SLC7A1 MNAT1	1.95e-04	197	137	7	371_DN
Drug	Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A	COL4A1 VPS39 DNAH7 GGA3 TDRD3 NFIB ALCAM	1.95e-04	197	137	7	3620_DN
Drug	Norethindrone [68-22-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	GPRASP1 MAPT CEP162 SLC7A1 MYOF EPS15L1 PPIL2	1.95e-04	197	137	7	5055_DN
Drug	haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A	SLC7A1 MYOF EPS15L1 ARRB2 NFIB RIN2 PPIL2	1.95e-04	197	137	7	7003_UP
Drug	Delsoline [509-18-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A	SSX1 SLC7A1 PHLDB1 DNAJC28 NFIB RIN2 AHNAK2	1.95e-04	197	137	7	7212_UP
Drug	Corynanthine hydrochloride [66634-44-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A	COL6A3 MAP4 MAPT NSD3 ITPR1 EPS15L1 ZNF592	1.95e-04	197	137	7	2786_UP
Drug	Pergolide mesylate [66104-23-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A	GPRASP1 MAP4 BCL7A NSD3 PHLDB1 PPIL2 SNX1	1.95e-04	197	137	7	7434_DN
Drug	Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A	MAPT PCLO ITPR1 DNAJC28 ZNF516 ALCAM SNX1	1.95e-04	197	137	7	4974_DN
Drug	Spironolactone [52-01-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A	COL4A1 ANK3 MAP4 CEP162 F5 NSD3 NFIB	1.95e-04	197	137	7	6255_UP
Drug	Deptropine citrate [2169-75-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A	DNAH3 PCLO NSD3 DHRS7B NMT2 PPIL2 SNX1	2.01e-04	198	137	7	5543_DN
Drug	Glimepiride [93479-97-1]; Up 200; 8.2uM; HL60; HT_HG-U133A	ANK3 MAP4 NSD3 MYOF PHLDB1 MAP4K1 PPIL2	2.01e-04	198	137	7	2154_UP
Drug	5286656; Down 200; 50uM; MCF7; HT_HG-U133A_EA	ANK3 BCL7A SSX1 CRAT NSD3 TDRD3 NFIB	2.01e-04	198	137	7	889_DN
Drug	Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; PC3; HT_HG-U133A	MAPT CEP162 SSX1 PACS1 DNAJC28 ZNF667 PPIL2	2.01e-04	198	137	7	4595_DN
Drug	Acemetacin [53164-05-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A	MAP4 VPS39 ZMYND8 CRAT NSD3 VPS9D1 SNX1	2.01e-04	198	137	7	7442_DN
Drug	Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; HL60; HT_HG-U133A	DNAH3 CFTR HUWE1 CRAT MAP4K1 MMP1 RAI1	2.01e-04	198	137	7	3017_UP
Drug	AG-028671 [847803-03-6]; Down 200; 10uM; MCF7; HT_HG-U133A	DNAH3 MAPT VPS39 NSD3 POLR3E NMT2 PPIL2	2.01e-04	198	137	7	6587_DN
Drug	Carbachol [51-83-2]; Down 200; 21.8uM; PC3; HT_HG-U133A	CEP162 ZMYND8 SLC7A1 TDRD3 ZNF667 PPIL2 RAB26	2.01e-04	198	137	7	6742_DN
Drug	Zoxazolamine [61-80-3]; Down 200; 23.8uM; MCF7; HT_HG-U133A	MAP4 ZMYND8 BCL7A CRAT JAK3 PHLDB1 PPIL2	2.01e-04	198	137	7	2625_DN
Drug	Flucytosine [2022-85-7]; Up 200; 31uM; HL60; HT_HG-U133A	ANK3 CILP CLIP2 MAP4 NAV2 PPIL2 MAP3K19	2.07e-04	199	137	7	3073_UP
Drug	2-propylpentanoic acid; Down 200; 2000uM; MCF7; HG-U133A	VPS39 IMPACT BCL7A C2CD5 MARF1 PPIL2 FGFBP1	2.07e-04	199	137	7	346_DN
Drug	5186324; Down 200; 2uM; MCF7; HT_HG-U133A_EA	MAP4 CEP162 ATG2B NSD3 TDRD3 NFIB ZNF516	2.07e-04	199	137	7	900_DN
Drug	Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; MCF7; HT_HG-U133A	CEP162 LAD1 BCL7A CRAT PHLDB1 ZNF516 PPIL2	2.07e-04	199	137	7	3266_DN
Drug	Thiethylperazine malate [52239-63-1]; Down 200; 6uM; PC3; HT_HG-U133A	PDS5B DNAH3 MAPT PCLO GGA3 MYOF NFIB	2.07e-04	199	137	7	5756_DN
Drug	Bupropion hydrochloride [31677-93-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A	MAP4 VPS39 PCLO APBA1 MYOF PHLDB1 RIN2	2.07e-04	199	137	7	6256_UP
Drug	Bephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; HL60; HT_HG-U133A	LAD1 APBA1 JAK3 NFIB NMT2 PPIL2 MMP1	2.07e-04	199	137	7	3089_UP
Drug	Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; HL60; HT_HG-U133A	ARHGAP32 MAP4 PCLO F5 SLC7A1 EPS15L1 ZNF667	2.13e-04	200	137	7	2905_DN
Disease	body weight	COL4A1 EHBP1 SLC39A11 CXXC5 HUWE1 BCL7A CLIP1 ITPR1 SLC7A1 TNNI3K FASN POLR3E RIN2 POC1B PXYLP1 FGR MGA	6.58e-05	1261	135	17	EFO_0004338
Disease	prion disease, Atypical behavior	COL4A1 ANK3	1.24e-04	4	135	2	EFO_0004720, HP_0000708
Disease	Psychomotor Agitation	MAPT RAI1	1.24e-04	4	135	2	C3887612
Disease	Akathisia	MAPT RAI1	1.24e-04	4	135	2	C0392156
Disease	chronic granulomatous disease (implicated_via_orthology)	NCF1C NCF1B	2.06e-04	5	135	2	DOID:3265 (implicated_via_orthology)
Disease	muscular disease (implicated_via_orthology)	FASN NMT2	2.06e-04	5	135	2	DOID:0080000 (implicated_via_orthology)
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	PDS5B SLC39A11 PACS1 UBN1 NFIB POC1B ALCAM SLC37A4	2.83e-04	364	135	8	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	Chronic obstructive pulmonary disease	CFTR MMP1	3.08e-04	6	135	2	cv:C0024117
Disease	portal hypertension (is_marker_for)	F5 ARRB2	3.08e-04	6	135	2	DOID:10762 (is_marker_for)
Disease	Bilateral Wilms Tumor	COL6A3 MAP3K4 XPO5	3.14e-04	29	135	3	C2930471
Disease	Nephroblastoma	COL6A3 MAP3K4 XPO5	5.99e-04	36	135	3	C0027708
Disease	kidney disease (implicated_via_orthology)	COL4A1 BLK FGR	8.79e-04	41	135	3	DOID:557 (implicated_via_orthology)
Disease	tauopathy (implicated_via_orthology)	MAP4 MAPT	9.13e-04	10	135	2	DOID:680 (implicated_via_orthology)
Disease	optic disc area measurement	F5 MNAT1 ARHGAP21	1.15e-03	45	135	3	EFO_0006937
Disease	rheumatoid arthritis (implicated_via_orthology)	NCF1C NCF1B	1.33e-03	12	135	2	DOID:7148 (implicated_via_orthology)
Disease	coffee consumption measurement	EHBP1 ZMYND8 NFIA HYDIN RAI1	1.53e-03	182	135	5	EFO_0006781
Disease	cerebral atherosclerosis	NFIB RIN2	1.82e-03	14	135	2	EFO_1000860
Disease	Maturity onset diabetes mellitus in young	BLK KCNJ11	1.82e-03	14	135	2	C0342276
Disease	cortical thickness	EHBP1 PDS5B MAPT NCKAP5 PHYH PHLDB1 UBN1 XPO5 NFIA NAV2 ALCAM ARHGAP21 ANKS1A	1.83e-03	1113	135	13	EFO_0004840
Disease	body fat percentage	PDS5B SLC39A11 PACS1 UBN1 NFIB POC1B ALCAM SLC37A4	1.88e-03	488	135	8	EFO_0007800
Disease	thrombosis (is_implicated_in)	F5 MMP1	2.10e-03	15	135	2	DOID:0060903 (is_implicated_in)
Disease	testosterone measurement	SPEM3 ANK3 TSHZ2 MAPT DNAH2 OPHN1 GGA3 FASN GTF3C2 NFIA FAM186A RIN2 ARHGAP21 RAI1	2.16e-03	1275	135	14	EFO_0004908
Disease	syndromic intellectual disability (implicated_via_orthology)	ZMYND8 OPHN1	2.39e-03	16	135	2	DOID:0050888 (implicated_via_orthology)
Disease	Monogenic diabetes	BLK KCNJ11	2.39e-03	16	135	2	C3888631
Disease	adverse effect, response to xenobiotic stimulus	CENPC NFIB NAV2	2.53e-03	59	135	3	EFO_0009658, GO_0009410
Disease	Dementia	COL4A1 MAPT	2.70e-03	17	135	2	C0497327
Disease	Dystonia, Limb	COL6A3 PRKRA	2.70e-03	17	135	2	C0751093
Disease	Dystonia, Diurnal	COL6A3 PRKRA	2.70e-03	17	135	2	C0393610
Disease	Dystonia, Paroxysmal	COL6A3 PRKRA	3.03e-03	18	135	2	C0393588
Disease	response to vaccine, cytokine measurement	DNAH3 BLK MNAT1 ARHGAP21	3.14e-03	131	135	4	EFO_0004645, EFO_0004873
Disease	coronary artery disease	COL4A1 EHBP1 PDS5B COL6A3 CFTR MAGI3 OPHN1 NFIA NFIB ALCAM ARHGAP21 RAI1 ANKS1A	3.34e-03	1194	135	13	EFO_0001645
Disease	reaction time measurement	MAPT SLC39A11 DCP2 NCKAP5 ELFN2 SPATS2L N4BP2 NAV2 RAI1	3.36e-03	658	135	9	EFO_0008393
Disease	cortical surface area measurement	ANK3 MAPT CEP162 NCKAP5 DNAH7 MSX2 NFIA NFIB KCNJ11 NAV2 ALCAM MNAT1 ARHGAP21 ANKS1A	3.50e-03	1345	135	14	EFO_0010736
Disease	neuroimaging measurement	ANK3 MAPT CXXC5 NCKAP5 MSX2 NFIA NFIB NAV2 ALCAM MNAT1 RAI1 ANKS1A	3.76e-03	1069	135	12	EFO_0004346
Disease	systemic lupus erythematosus	COL6A3 CLIP2 MAGI3 ELOF1 BLK EPS15L1 PHLDB1 CCDC116 AHNAK2 ANKS1A	3.79e-03	799	135	10	MONDO_0007915
Disease	Ischemic stroke	COL4A1 COL6A3 F5 NFIA ZNF516 ARHGAP21	3.85e-03	324	135	6	HP_0002140
Disease	Malignant neoplasm of breast	EHBP1 VPS39 MAGEE1 TTC3 SHROOM2 CLIP1 GGA3 FASN ZNF532 N4BP2 MMP1 CLSPN	3.90e-03	1074	135	12	C0006142
Disease	tissue plasminogen activator measurement, coronary artery disease	COL4A1 MAP3K4 ANKS1A	4.27e-03	71	135	3	EFO_0001645, EFO_0004791
Disease	Manic Disorder	ANK3 PACS1 ZNF592	4.27e-03	71	135	3	C0024713
Disease	Hepatitis	PDS5B NAV2	4.52e-03	22	135	2	HP_0012115
Disease	portal hypertension (biomarker_via_orthology)	F5 ARRB2	4.52e-03	22	135	2	DOID:10762 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
SGDKVKPVLMNSKLP	EPS15L1	146	Q9UBC2
KKKPLPSISSKSSMS	CCDC116	411	Q8IYX3
FIDMPTEGKPTKSTK	CFTR	1166	P13569
KPVKPSGVMKSSDEL	BRDT	811	Q58F21
GMSSDLPPKKSKDKL	GZF1	191	Q9H116
FGNTKPRKEKTEMSP	FGFBP1	156	Q14512
SKFKMPFLSISSPKV	AHNAK	3401	Q09666
ASEGSIKLPKMKLPQ	AHNAK	5396	Q09666
SGSGKVTFPKMKIPK	AHNAK	5651	Q09666
VTFPKMKIPKFTFSG	AHNAK	5656	Q09666
KPLGFLKPFSLMKAS	CRAT	11	P43155
PSTSPAKAKKTKRMA	CLIP2	291	Q9UDT6
MTGKRSTKEVDKTPP	ANKS1A	306	Q92625
DMTPKSKLGLAPNKF	DCP2	211	Q8IU60
PPKKKMTGTLETQFT	ELOF1	11	P60002
MGEKPGTRVFKKSSP	ARRB2	1	P32121
MVSPGTLSIEPKKTK	ATG2B	1961	Q96BY7
MFKKPTPSTLKAGEL	COL4A1	1641	P02462
GMPSPTTLKKSEKSG	NFIA	316	Q12857
SPTLFKRMSSPKKAK	RAI1	1266	Q7Z5J4
MSRKKTPKSKGASTP	RAB26	1	Q9ULW5
MKSFFTPGKPKTTNV	PDS5B	1116	Q9NTI5
DYTMSSPLPGKKSDK	PDS5B	1186	Q9NTI5
TPKEEPTMKTSKKGS	PDS5B	1301	Q9NTI5
EPSTSATVPMSKKKP	PPIL2	496	Q13356
ATVPMSKKKPSRGFG	PPIL2	501	Q13356
SSPTTMKKPEKPLFS	NFIB	311	O00712
GVTMPISALDPAKKL	JAK3	721	P52333
KTLTMTPMEQKPGAK	OPHN1	296	O60890
KGVPEKSPVLEKSSM	LAD1	171	O00515
KSPVLEKSSMPKKTA	LAD1	176	O00515
SKMLALKCPSSSGKP	LSM12	36	Q3MHD2
KPVKPVTFSTGIKMG	MNAT1	216	P51948
FLLMDSTKLPIPKKG	MAGEE1	756	Q9HCI5
GKPAEVKKMTAKSVP	MAP4	841	P27816
GPPSPTKTAKMKTDK	MAGI3	656	Q5TCQ9
KTSGLRPMEPKDIKS	NMT2	336	O60551
RKMDTTTPLKGIPKQ	NELFA	206	Q9H3P2
TKVAVKTLKPGTMSP	FGR	286	P09769
KTLKPGTMSPKAFLE	FGR	291	P09769
LPSSPSGVAKAKMFK	MGA	446	Q8IWI9
EKPVMLKIGTSPVKE	ITPR1	411	Q14643
RSVPMAKAKPKFSIS	KCNJ11	371	Q14654
HKKSLIDPKMSKFSP	PCLO	4191	Q9Y6V0
PMSSPGLGKKRKVSL	RASGRP4	181	Q8TDF6
VSRKKLGNPMTPTEK	DNAJC28	276	Q9NX36
LELKMISTPSPKKSM	NCBP3	406	Q53F19
SMKVKLQPPSGTELS	GGA3	651	Q9NZ52
LMSPECLPTTTKKKT	POC1B	396	Q8TC44
FSPKIGRKLSKSPSM	ARHGAP32	891	A7KAX9
KQKGKGSKPLMPTST	HUWE1	2056	Q7Z6Z7
KSQMTEPGPDVKKKT	IMPACT	116	Q9P2X3
KKPSAALEKVMLPTG	CXXC5	301	Q7LFL8
KPETYLMPKDGKSTA	NCF1B	136	A6NI72
KPETYLMPKDGKSTA	NCF1C	111	A8MVU1
KPKLKPFFEGMSQSS	PACS1	396	Q6VY07
PMPSEGKKGSLKEES	SLC37A4	201	O43826
PMKKEAKPSATGKVI	CCNB1	61	P14635
ILKPEKPDLSITMKG	HYDIN	4766	Q4G0P3
PPLSEKKMKAINSLG	KDM1B	641	Q8NB78
PMKKEVKTSLTFPGS	DNAH3	186	Q8TD57
KQMPPVGSKKSSTRK	CENPC	476	Q03188
MGLVSSKKPDKEKPI	BLK	1	P51451
KPAATKPATTKPMVK	COL6A3	2976	P12111
ITVVKSMKSPPAGVK	DNAH7	2691	Q8WXX0
PPSMKGKIKSKAIIS	CTR9	1001	Q6PD62
KSRKKAPEGESQPMT	APBA1	501	Q02410
TSKVDPKLRTPIKMG	ANK3	3711	Q12955
GKPSSPLKMFSTLEK	CEP162	516	Q5TB80
SPMPTQTDVKLKFKP	EHBP1	126	Q8NDI1
KMEIPIPGKSKTLTS	MARF1	1671	Q9Y4F3
SKGKEATLTKPMVGP	IZUMO1	211	Q8IYV9
MVSPATRKSLPKVKA	DHRS7B	1	Q6IAN0
QKVKSGPGVMLSKSP	CCDC168	5191	Q8NDH2
SVSDTKKPKVMVPPS	FAM186A	2081	A6NE01
PEAVLKGAKPKLMSA	FASN	1861	P49327
SQDLEGVPPSKKMKL	BCL7A	186	Q4VC05
VSIKMTTEPPKGLKA	DNAH2	3941	Q9P225
SPKILMSKPVLSGGT	ZMYND8	406	Q9ULU4
FGSTLMKKKSDPEGP	SLC39A11	116	Q8N1S5
LVKETMPKKPDAQSG	POLR3E	436	Q9NVU0
PQIKMTKKTDPSGLS	ALCAM	416	Q13740
KMTPLSFIPGAKITK	C2CD5	876	Q86YS7
TEGPIKPTMHKTSIK	MAP3K19	556	Q56UN5
MSMLKPSGLKAPTKI	CLIP1	1	P30622
MPRGFLVKRSKKSTP	INSM1	1	Q01101
TMLINKPPDSGKKTS	PHYH	156	O14832
LSGKTSVLSMKPPEA	CFAP221	631	Q4G0U5
EKLKMAAKPMLPSSF	MSX2	206	P35548
MLDSVGGSLPKKSIP	MAP3K4	166	Q9Y6R4
TKSPKKRPSATKMLS	MAP4K1	256	Q92918
RPKNKSKVMPGASTK	GPRASP1	51	Q5JY77
MGKAKVPASKRAPSS	REXO4	1	Q9GZR2
MSKISLNTPPGTKVK	TDRD3	21	Q9H7E2
KPSEGKAANPKMVSS	SPATS2L	396	Q9NUQ6
PGSFKTLEMKASKPG	F5	1866	P12259
RGKSSPQKSKLMEPE	NCKAP5	806	O14513
PSKEEKSKTPPMFLC	NCOA7	646	Q8NI08
TGKPDAETLKVMKQP	MMP1	76	P03956
SAPLKKTKSSMLPPK	FAM120AOS	166	Q5T036
VASKMKSGLPKPVHS	NAV2	6	Q8IVL1
AVPEMPKKSSKIASF	NAV2	551	Q8IVL1
TSPPGLSYMKAKEKT	SHROOM2	1296	Q13796
PVSTPKNGMSSKSRK	PXYLP1	31	Q8TE99
KKGRITPSQVKMSPS	VPS8	1326	Q8N3P4
SVLEKTTTKAPGKMP	SSC5D	611	A1L4H1
KAMTKLGFKVTLPPF	SSX1	56	Q16384
MGNEPTPTKSLSKIA	AKAP3	161	O75969
KGPKAEVTAPDVKMS	AHNAK2	781	Q8IVF2
KGPKVEVTAPDVKMS	AHNAK2	1606	Q8IVF2
KGPKAEVTAPDVKMS	AHNAK2	2761	Q8IVF2
KGPKAEVTAPDVKMS	AHNAK2	4081	Q8IVF2
KFAPIVLTMPKTSLK	CILP	281	O75339
PPGSSKTTMIDTLKK	C12orf60	176	Q5U649
KSQVKKRGPSFMTSP	CLSPN	1301	Q9HAW4
HKGITKMTKEEIPPS	XIRP2	1331	A4UGR9
MPSARGKSKSKAPIT	ZNF667	1	Q5HYK9
ETMAPPIKSKKKRSS	RIN2	471	Q8WYP3
SSPLGVVTKAASMPK	ZNF516	851	Q92618
SMNGKEKLEKKSPSP	ZNF532	996	Q9HCE3
MGLRKKSTKNPPVLS	TRAM1L1	1	Q8N609
LASIMSKLPLATPKK	UBN2	806	Q6ZU65
ETTVMKSAPKALRPK	ZSCAN5DP	201	P0CG00
SMKETEKGPLSPKVL	USP45	261	Q70EL2
PPEKSLIGMTKVKVG	SNX1	211	Q13596
PKSTLSLMKSSVPEK	SPEM3	1041	A0A1B0GUW6
LSPKNMEPSKISGLI	SLC7A1	481	P30825
EMAKAAPGSTKPKKT	SCAF1	886	Q9H7N4
LSGPTKESSKGSPKM	ZNF592	311	Q92610
PSLFKKTKPMLETEV	XPO5	1176	Q9HAV4
KKPKDSKPMLVGSGT	TTC3	1026	P53804
PMPDLKNVKSKIGST	MAPT	566	P10636
RPFPKTTSTLKEMEK	PHLDB1	901	Q86UU1
ADMVKVLPKATTPKP	TSHZ2	796	Q9NRE2
LMKLPMIPSSSASKK	NSD3	901	Q9BZ95
FSLGKMITAKPGKTP	PRKRA	21	O75569
RTTKDDPKGSSKMPA	ZDHHC23	236	Q8IYP9
PSSAGKKMPVSQKLT	UBN1	951	Q9NPG3
MFPKTSVSPAPDKTK	ZNF217	841	O75362
VKPSKMLKPSGTPFS	ZBED9	666	Q6R2W3
SEMSKVSKPRASKPG	GTF3C2	86	Q8WUA4
PMAGSKKTSSPTERK	TCHHL1	211	Q5QJ38
GETVPPDTSKMLKLA	VPS9D1	61	Q9Y2B5
GIPSIMRKTFEKKPT	ARHGAP21	1126	Q5T5U3
VSVPSPLGKIKSMTK	TNNI3K	426	Q59H18
EKLMGKTTKTRGPKP	TTLL7	516	Q6ZT98
ATKKSKEKEPGMALP	ZNF816	6	Q0VGE8
SPLMEGTPTIKSKKK	VPS39	441	Q96JC1
KALKNGVPSPIMATK	TTLL13	46	A6NNM8
ASIPSMIGEKLPTAK	ELFN2	471	Q5R3F8
PGILKATTPKDMSET	N4BP2	1251	Q86UW6
LKKTPNFPSSVLFMK	MYOF	1346	Q9NZM1